Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

Adams, 2005, The natural history of nonalcoholic fatty liver disease: a population-based cohort study, Gastroenterology, 129, 113, 10.1053/j.gastro.2005.04.014

Bhala, 2011, The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study, Hepatology, 54, 1208, 10.1002/hep.24491

Wong, 2012, Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography, Gut, 61, 409, 10.1136/gutjnl-2011-300342

Anstee, 2013, Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis, Nat Rev Gastroenterol Hepatol, 10, 330, 10.1038/nrgastro.2013.41

Vernon, 2011, Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults, Aliment Pharmacol Ther, 34, 274, 10.1111/j.1365-2036.2011.04724.x

Michelotti, 2013, NAFLD, NASH and liver cancer, Nat Rev Gastroenterol Hepatol, 10, 656, 10.1038/nrgastro.2013.183

Ekstedt, 2006, Long-term follow-up of patients with NAFLD and elevated liver enzymes, Hepatology, 44, 865, 10.1002/hep.21327

Musso, 2011, Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity, Ann Med, 43, 617, 10.3109/07853890.2010.518623

Sanyal, 2011, Endpoints and clinical trial design for nonalcoholic steatohepatitis, Hepatology, 54, 344, 10.1002/hep.24376

Chalasani, 2012, The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, Hepatology, 55, 2005, 10.1002/hep.25762

Nascimbeni, 2013, From NAFLD in clinical practice to answers from guidelines, J Hepatol, 59, 859, 10.1016/j.jhep.2013.05.044

Vilar Gomez, 2009, Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease, Aliment Pharmacol Ther, 30, 999, 10.1111/j.1365-2036.2009.04122.x

Promrat, 2010, Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis, Hepatology, 51, 121, 10.1002/hep.23276

Sullivan, 2012, Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease, Hepatology, 55, 1738, 10.1002/hep.25548

Thoma, 2012, Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review, J Hepatol, 56, 255, 10.1016/j.jhep.2011.06.010

Wong, 2013, Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial, J Hepatol, 59, 536, 10.1016/j.jhep.2013.04.013

Dixon, 2004, Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss, Hepatology, 39, 1647, 10.1002/hep.20251

Eckard, 2013, Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial, Therap Adv Gastroenterol, 6, 249, 10.1177/1756283X13484078

Lazo, 2010, Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes, Diabetes Care, 33, 2156, 10.2337/dc10-0856

Harrison, 2009, Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial, Hepatology, 49, 80, 10.1002/hep.22575

Petersen, 2005, Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes, Diabetes, 54, 603, 10.2337/diabetes.54.3.603

Ray, 2003, Evaluating medication effects outside of clinical trials: new-user designs, Am J Epidemiol, 158, 915, 10.1093/aje/kwg231

Silverman, 2009, From randomized controlled trials to observational studies, Am J Med, 122, 114, 10.1016/j.amjmed.2008.09.030

Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701

Perula de Torres, 2005, [Validation of the AUDIT test for identifying risk consumption and alcohol use disorders in women], Aten Primaria, 36, 499

Reinert, 2002, The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research, Alcohol Clin Exp Res, 26, 272, 10.1111/j.1530-0277.2002.tb02534.x

Bush, 1998, The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test, Arch Intern Med, 158, 1789, 10.1001/archinte.158.16.1789

Mifflin, 1990, A new predictive equation for resting energy expenditure in healthy individuals, Am J Clin Nutr, 51, 241, 10.1093/ajcn/51.2.241

Baecke, 1982, A short questionnaire for the measurement of habitual physical activity in epidemiological studies, Am J Clin Nutr, 36, 936, 10.1093/ajcn/36.5.936

2002, Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report, Circulation, 106, 3143, 10.1161/circ.106.25.3143

Brunt, 2007, Pathology of fatty liver disease, Mod Pathol, 20, S40, 10.1038/modpathol.3800680

Yeh, 2007, Pathology of nonalcoholic fatty liver disease, Am J Clin Pathol, 128, 837, 10.1309/RTPM1PY6YGBL2G2R

Brunt, 2009, Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network, Hepatology, 49, 809, 10.1002/hep.22724

Flegal, 2012, Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010, JAMA, 307, 491, 10.1001/jama.2012.39

Peng, 2011, Weight reduction for non-alcoholic fatty liver disease, Cochrane Database Syst Rev, CD003619

Tuomilehto, 2001, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med, 344, 1343, 10.1056/NEJM200105033441801

Avenell, 2004, What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials, J Hum Nutr Diet, 17, 317, 10.1111/j.1365-277X.2004.00531.x

Pi-Sunyer, 2007, Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial, Diabetes Care, 30, 1374, 10.2337/dc07-0048

Promrat, 2004, A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis, Hepatology, 39, 188, 10.1002/hep.20012

Liu, 2007, Resolution of nonalcoholic steatohepatits after gastric bypass surgery, Obes Surg, 17, 486, 10.1007/s11695-007-9086-2

Barker, 2006, Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery, Am J Gastroenterol, 101, 368, 10.1111/j.1572-0241.2006.00419.x

Franz, 2007, Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up, J Am Diet Assoc, 107, 1755, 10.1016/j.jada.2007.07.017

Wadden, 2012, Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy, Circulation, 125, 1157, 10.1161/CIRCULATIONAHA.111.039453

Rosal, 2008, Opportunities and challenges for diabetes prevention at two community health centers, Diabetes Care, 31, 247, 10.2337/dc07-0746

Vermunt, 2011, Lifestyle counseling for type 2 diabetes risk reduction in Dutch primary care: results of the APHRODITE study after 0.5 and 1.5 years, Diabetes Care, 34, 1919, 10.2337/dc10-2293